Site Search

Foundation to fund up to $110 million for collaboration to accelerate the development of genetic therapies for CF

The Cystic Fibrosis Lung Transplant Consortium Biorepository and Patient Registry, in collaboration with Cleveland Clinic, will provide critical clinical data and samples to support future research investigating complications of lung transplant.

The Cystic Fibrosis Foundation supports universal masking in school to protect people with CF and other health conditions against COVID-19.

The treatment has the potential to prevent Aspergillus fungal infections in people who have had a lung transplant.

The Cystic Fibrosis Foundation announced the recipients of its sixth annual Impact Grants.

Marissa Benchea and Jeremy and Rachel Olimb to lead the Foundation’s volunteer advocacy base into a new chapter of CF

The studies aim to improve early detection of chronic lung allograft dysfunction (CLAD), the leading cause of lung transplant failures.

The Cystic Fibrosis Foundation awarded up to $4.7 million to EnBiotix Inc. to study the potential use of inhaled colistin as an additional option to treat Pseudomonas infections in people with cystic fibrosis who are not responding to current treatments.

The Cystic Fibrosis Foundation awarded up to $3.5 million to Arrevus Inc. to test a potential treatment for pulmonary exacerbations in people with cystic fibrosis in a late phase clinical trial.